Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants
Public ClinicalTrials.gov record NCT05274100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Pharmacokinetic Comparability Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Subjects
Study identification
- NCT ID
- NCT05274100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 394 participants
Conditions and interventions
Conditions
Interventions
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2020
- Primary completion
- Jul 5, 2021
- Completion
- Jul 5, 2021
- Last update posted
- Mar 9, 2022
2020 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials LLC /ID# 222821 | Anaheim | California | 92801-2658 | — |
| Altasciences Clinical Los Angeles, Inc /ID# 222238 | Cypress | California | 90630 | — |
| Clinical Pharmacology of Miami /ID# 225392 | Miami | Florida | 33014 | — |
| PPD Clinical Research Unit /ID# 222362 | Orlando | Florida | 32806-1044 | — |
| Acpru /Id# 222349 | Grayslake | Illinois | 60030 | — |
| PPD Clinical Research Unit -Las Vegas /ID# 222363 | Las Vegas | Nevada | 89113-2235 | — |
| PPD Clinical Research Unit - Austin /ID# 222361 | Austin | Texas | 78744 | — |
| Spaulding Clinical Research LLC /ID# 225405 | West Bend | Wisconsin | 53095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05274100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05274100 live on ClinicalTrials.gov.